1. Can we turn to our next page in nuclear cardiology?

   • Leslee J. Shaw
   • Ami E. Iskandrian

   Editor's Page 08 May 2017 Pages: 757 - 757

   

2. A quick glance at selected topics in this issue

   • Pradeep Bhambhvani
   • Fadi G. Hage
   • Ami E. Iskandrian

   Review Article 06 April 2017 Pages: 758 - 760

3. Nuclear cardiology in the literature: A selection of recent, original research papers

   • Saurabh Malhotra
   • Prem Soman

   Review of the Literature 28 March 2017 Pages: 761 - 763

4. Cardiovascular disease in the literature: A selection of recent original research papers

   • Wael A. AlJaroudi
   • Fadi G. Hage

   Review of the Literature 23 March 2017 Pages: 764 - 766

5. What is this image? 2017: Image 1

   WHAT IS THIS IMAGE? 01 May 2017 Pages: 767 - 767

   

6. What is This Image? 2017: Image 6 Result

   • Ahmed Fathala

   WHAT IS THIS IMAGE? 31 March 2017 Pages: 768 - 771

   

7. Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients

   • Philip Haaf
   • Myriam Ritter
   • On behalf of the BARDOT study group

   Original Article 13 January 2017 Pages: 772 - 782

   

8. The interface of emotion and biology in myocardial ischemia: Can we progress using the traditional paradigm?

   • Robert Soufer
   • Matthew M. Burg

   Editorial 02 February 2017 Pages: 783 - 787

   

9. The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol

   • Gregory S. Thomas
   • S. James Cullom
   • Randall C. Thompson

   Original Article Open access 21 February 2017 Pages: 788 - 802

   

10. Regadenoson stress during low-level exercise: The EXERRT trial—does it move the needle?

    • John J. Mahmarian

    Editorial 15 May 2017 Pages: 803 - 808

    

11. Multicenter evaluation of stress-first myocardial perfusion image triage by nuclear technologists and automated quantification

    • Waseem Chaudhry
    • Nasir Hussain
    • W. Lane Duvall

    Original Article 13 November 2015 Pages: 809 - 820

    

12. Implementation of stress-only imaging: What will it take?

    • John J. Mahmarian

    Editorial 15 December 2015 Pages: 821 - 825

    

13. Coronary artery calcium score as a gatekeeper in the non-invasive evaluation of suspected coronary artery disease in symptomatic patients

    • Elsemiek M. Engbers
    • Jorik R. Timmer
    • Jan Paul Ottervanger

    Debate Article 01 February 2017 Pages: 826 - 831

    

14. Coronary Calcium Scoring as the Gate Keeper for Stress Myocardial Perfusion Imaging: Antagonist

    • Shane M. Ruckel
    • Martha Gulati

    Debate Article 31 January 2017 Pages: 832 - 834

15. Coronary artery calcium scanning in symptomatic patients: Ready for use as a gatekeeper for further testing?

    • Alan Rozanski
    • Daniel S. Berman

    Editorial 15 February 2017 Pages: 835 - 838

    

16. Evaluation of attenuation correction in cardiac PET using PET/MR

    • Jeffrey M. C. Lau
    • R. Laforest
    • P. K. Woodard

    Original Article 23 October 2015 Pages: 839 - 846

    

17. The foundation layer of quantitative cardiac PET/MRI: Attenuation correction. Again

    • Stephan G. Nekolla
    • Jorge Cabello

    Editorial 23 February 2016 Pages: 847 - 850

    

18. Opportunities for improvement on current nuclear cardiology practices and radiation exposure in Latin America: Findings from the 65-country IAEA Nuclear Cardiology Protocols cross-sectional Study (INCAPS)

    • João V. Vitola
    • Fernando Mut
    • The INCAPS Investigators Group

    Original Article 22 February 2016 Pages: 851 - 859

    

19. A world view of nuclear cardiology practices: Think globally, act locally

    • Thomas A. Holly

    Editorial 25 February 2016 Pages: 860 - 861

20. 18-kDa translocator protein ligand ¹⁸F-FEMPA: Biodistribution and uptake into atherosclerotic plaques in mice

    • Sanna Hellberg
    • Johanna M. U. Silvola
    • Antti Saraste

    Original Article 25 May 2016 Pages: 862 - 871

    

21. Targeting activated macrophages to identify the vulnerable atherosclerotic plaque

    • Lynne L. Johnson

    Editorial 01 June 2016 Pages: 872 - 875

22. Comparative analysis of full-time, half-time, and quarter-time myocardial ECG-gated SPECT quantification in normal-weight and overweight patients

    • M. Lecchi
    • I. Martinelli
    • A. Del Sole

    Original Article 24 February 2016 Pages: 876 - 887

    

23. Optimizing radiation dose and imaging time with conventional myocardial perfusion SPECT: Technical aspects

    • Piotr Slomka
    • Guido Germano

    Editorial 08 March 2016 Pages: 888 - 891

    

24. Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease

    • Seung Hwan Moon
    • Sun-pyo Hong
    • Kyung-Han Lee

    Original Article 28 October 2015 Pages: 892 - 899

    

25. Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?

    • Aukelien C. Dimitriu-Leen
    • Arthur J. H. A. Scholte

    Editorial Open access 04 January 2016 Pages: 900 - 902

26. CME INSTRUCTIONS: Comprehensive review on cardio-oncology: Role of multimodality imaging

    CME Instructions 08 June 2017 Pages: 903 - 905

27. Comprehensive review on cardio-oncology: Role of multimodality imaging

    • Carol Chen-Scarabelli
    • Chad McRee
    • Tiziano M. Scarabelli

    Review Article 25 May 2016 Pages: 906 - 935

    

28. Editor Highlight Interview: Multi-modality imaging and clinical issues in cardio-oncology

    • Tiziano M. Scarabelli
    • Ami E. Iskandrian

    Editor Highlight Interview 20 May 2016 Pages: 936 - 937

29. Molecular imaging of atherosclerosis with integrated PET imaging

    • Basma Hammad
    • Nicholas R. Evans
    • Ahmed Tawakol

    Molecular Imaging Corner Open access 11 January 2017 Pages: 938 - 943

    

30. Technologist corner: Reducing the small-heart effect in pediatric gated myocardial perfusion single-photon emission computed tomography

    • Robert Pagnanelli
    • Heidi Camposano
    • Salvador Borges-Neto

    Technologist Corner 20 June 2016 Pages: 944 - 945

31. Multi-modality imaging: Bird’s eye view from the 2016 American Heart Association Scientific Sessions

    • Wael A. AlJaroudi
    • Steven G. Lloyd
    • Fadi G. Hage

    Review Article 15 February 2017 Pages: 946 - 951

32. Cardiac sympathetic nervous system imaging with ¹²³I-meta-iodobenzylguanidine: Perspectives from Japan and Europe

    • Kenichi Nakajima
    • Arthur J.H.A. Scholte
    • Keiichiro Yoshinaga

    INTERNATIONAL CORNER 13 March 2017 Pages: 952 - 960

    

33. The effect of coronary revascularization on regional myocardial blood flow as assessed by stress positron emission tomography

    • Robert M. Bober
    • Caleb D. Thompson
    • Daniel P. Morin

    Original Article 28 March 2016 Pages: 961 - 974

    

34. Guiding coronary revascularization using PET stress myocardial perfusion imaging: The proof is in the pudding

    • Ajay V. Srivastava
    • Karthik Ananthasubramaniam

    Editorial 31 March 2016 Pages: 975 - 979

35. Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging

    • Felix Nensa
    • E. Tezgah
    • T. D. Poeppel

    Original Article 18 March 2016 Pages: 980 - 988

    

36. Continuing evolution in preparation protocols for ¹⁸FDG PET assessment of inflammatory or malignant myocardial disease

    • John P. Bois
    • Panithaya Chareonthaitawee

    Editorial 25 March 2016 Pages: 989 - 992

37. The impact of combination of regadenoson and isometric exercise on image quality of myocardial perfusion scintigraphy

    • Quentin Ceyrat
    • Charles Mesguich
    • Jean-baptiste Pinaquy

    Brief Report 01 November 2016 Pages: 993 - 997

    

38. Interpreting the change in left ventricular ejection fraction during pharmacological coronary vasodilation: Proceed with caution!

    • Steven Port

    Debate Article 07 March 2017 Pages: 998 - 1001

39. Clinical value of hyperemic left ventricular systolic function in vasodilator stress testing

    • Venkatesh L. Murthy
    • Sharmila Dorbala

    Debate Article 07 March 2017 Pages: 1002 - 1006

    

40. Cardiovascular PET/MR imaging: Quo Vadis?

    • Thomas Hellmut Schindler

    Theme Article 22 September 2016 Pages: 1007 - 1018

    

41. PET/MR: Yet another Tesla?

    • Markus Schwaiger
    • Karl Kunze
    • Stephan G. Nekolla

    Theme Article 22 September 2016 Pages: 1019 - 1031

    

42. Cardiovascular PET/MR: We need evidence, not hype

    • Afshin Farzaneh-Far
    • Raymond Y. Kwong

    Editorial 29 November 2016 Pages: 1032 - 1035

43. Comparative analysis of iterative reconstruction algorithms with resolution recovery and time of flight modeling for ¹⁸F-FDG cardiac PET: A multi-center phantom study

    • Roberta Matheoud
    • Michela Lecchi
    • Orazio Zoccarato

    Original Article 12 January 2016 Pages: 1036 - 1045

    

44. Comparison of ESC and ACC/AHA guidelines for myocardial revascularization

    • Jim Stirrup
    • Alejandro Velasco
    • Eliana Reyes

    Review Article Open access 21 February 2017 Pages: 1046 - 1053

    

45. The unsaid word

    • Timothy F. Christian

    Editorial 24 May 2017 Pages: 1054 - 1056

46. Comparison of ESC and ACC/AHA guidelines for myocardial revascularization: are the differences clinically relevant? The European perspective

    • Mario Petretta
    • Alberto Cuocolo

    Editorial 21 April 2017 Pages: 1057 - 1061

47. RETRACTED ARTICLE: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI

    • Jesse A. Doran
    • Waseem Sajjad
    • Ronald G. Schwartz

    Original Article 29 March 2016 Pages: 1062 - 1070

    

48. Intravenous caffeine: An alternative to aminophylline to reverse adverse effects during regadenoson myocardial perfusion imaging

    • Aaron F. Jolly
    • Gregory S. Thomas

    Editorial 12 April 2016 Pages: 1071 - 1074

    

49. PET/CT evaluation of ¹⁸F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions' formation?

    • Tomasz Mazurek
    • Małgorzata Kobylecka
    • Grzegorz Opolski

    Original Article 07 March 2016 Pages: 1075 - 1084

    

50. Editorial in response to: PET/CT evaluation of ¹⁸F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesion formation?

    • Stephanie L. Thorn
    • Albert J. Sinusas

    Editorial 14 March 2016 Pages: 1085 - 1088